IDEAYA Biosciences (IDYA) FCF Margin (2020 - 2026)
IDEAYA Biosciences (IDYA) reported FCF Margin of 1160.62% for Q1 2026, down 36.86% sequentially from 848.06% in Q4 2025.
IDEAYA Biosciences (IDYA) FCF Margin (2020 - 2026) Analysis & Trends
IDEAYA Biosciences (IDYA) has 7 years of FCF Margin data on file, last reported at 1160.62% in Q1 2026.
- For the quarter ending Q1 2026, FCF Margin changed N/A year-over-year to 1160.62%; the trailing twelve-month figure through Mar 2026 stood at 38.15% (changed N/A YoY), and the FY2025 full-year result was 33.59%, up 352445.0% from the prior year.
- FCF Margin eased to 1160.62% in Q1 2026, from 848.06% in the prior quarter.
- In the past five years, FCF Margin ranged from a high of 69.08% in Q3 2025 to a low of 1740.8% in Q4 2024.
- A 5-year average of 593.26% and a median of 445.98% in 2022 frame the typical range for FCF Margin.
- Across the five-year window, FCF Margin slumped 111393 bps in 2024 and surged 89274 bps in 2025, its largest moves.
- Tracing IDYA's FCF Margin over 5 years: stood at 505.0% in 2022, then dropped by 24 bps to 626.87% in 2023, then slumped by 178 bps to 1740.8% in 2024, then surged by 51 bps to 848.06% in 2025, then plunged by 37 bps to 1160.62% in 2026.
- Business Quant data shows IDYA's FCF Margin at 1160.62% in Q1 2026, 848.06% in Q4 2025, and 69.08% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 10.45% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 43.35% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 23.53% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | IDEAYA Biosciences | 3.21 Bn | 2.54 Bn | - | -1,160.63% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1,160.63% |
| Dec 31, 2025 | -848.06% |
| Sep 30, 2025 | 69.08% |
| Dec 31, 2024 | -1,740.80% |
| Dec 31, 2023 | -626.87% |
| Sep 30, 2023 | -386.96% |
| Jun 30, 2023 | -940.01% |
| Mar 31, 2023 | -362.79% |
| Dec 31, 2022 | -505.00% |
| Sep 30, 2022 | -89.52% |
| Jun 30, 2022 | -349.74% |
| Mar 31, 2022 | -177.81% |
| Dec 31, 2021 | -582.78% |
| Sep 30, 2021 | -144.01% |
| Jun 30, 2021 | -161.35% |
| Mar 31, 2021 | -194.66% |
| Dec 31, 2020 | -111.65% |
| Sep 30, 2020 | 1,005.34% |